• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

ESALF:US

42.8500 USD 2.8500 7.13%

As of 20:10:05 ET on 01/15/2015.

Snapshot for Eisai Co Ltd (ESALF)

Open: 42.8500 Day's Range: 42.8500 - 42.8500 Volume: 159
Previous Close: 40.0000 52wk Range: 35.8500 - 42.8500 1-Yr Rtn: -

Stock Chart for ESALF

No chart data available.
  • ESALF:US 42.8500
  • 1D
  • 1M
  • 1Y
40.0000
Interactive ESALF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ESALF

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) 52.8681
Relative P/E vs. SPX -
Earnings Per Share (JPY) (ttm) -
Est. EPS (JPY) (03/2015) 95.9560
Est. PEG Ratio 8.7385
Market Cap (M USD) 12,707.89
Shares Outstanding (M) 296.57
30 Day Average Volume 24
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.07%
Cash Dividend (JPY) 80.0000
Dividend Ex-Date 03/27/2015
5 Year Dividend Growth -0.92%
Next Earnings Announcement 01/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ESALF

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for ESALF

Eisai Co., Ltd. produces prescription drugs and medical equipment and sells mainly to sales agents and subsidiaries. Through its subsidiary, Sanko Junyaku, the Company produces and sells diagnostic drugs. Eisai also markets its products through related companies in the US, Europe, and Asia. The Company also manufactures and sells foods, livestock feeds, chemical, and agrochemicals.

Hideaki MatsuiDirectorNobuo DeguchiDirector
Noboru NaoeDirectorHaruo NaitoRep Corporate Officer/CEO
More Company Profile & Key Executives for ESALF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil